Currently, AMGEN Inc [AMGN] is trading at $297.29, up 1.88%. An important factor to consider is whether the stock is rising or falling in short-term value. The AMGN shares have gain 3.55% over the last week, with a monthly amount glided 9.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wolfe Research started tracking the stock assigning a Peer Perform rating. Citigroup initiated its recommendation with a Neutral and recommended $335 as its price target on November 14, 2024. Bernstein started tracking with a Outperform rating for this stock on October 17, 2024, and assigned it a price target of $380. In a note dated October 14, 2024, Truist downgraded an Hold rating on this stock and boosted its target price from $320 to $333.
This stock has fluctuated between a low of $253.30 and a high of $346.85 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $304.67 within the next 12 months. AMGEN Inc [NASDAQ: AMGN] shares were valued at $297.29 at the most recent close of the market. An investor can expect a potential return of 2.48% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
Trailing Twelve Months sales for AMGEN Inc [NASDAQ:AMGN] were 33.93B which represents 9.42% growth. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.93 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of9.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AMGEN Inc [NASDAQ:AMGN] is 1.17. On the other hand, the Quick Ratio is 0.88, and the Cash Ratio is 0.38. Considering the valuation of this stock, the price to sales ratio is 4.71, the price to book ratio is 25.75 and price to earnings (TTM) ratio is 27.14.
Transactions by insiders
Recent insider trading involved Khosla Rachna, SVP, Business Development, that happened on Jun 05 ’25 when 1500.0 shares were sold. Officer, Khosla Rachna completed a deal on Jun 05 ’25 to buy 1500.0 shares. Meanwhile, VP, Finance & CAO Busch Matthew C. sold 1000.0 shares on May 02 ’25.
